PD-L1 expression in colorectal cancer defines three subsets of tumor immune microenvironments.

Oncotarget
Anna Maria ValentiniMichele Pirrelli

Abstract

We investigated the PD-L1 expression in colorectal cancer (CRC) and in its microenvironment. PD-L1 was expressed in neoplastic cells (NCs) and tumor-infiltrating immune cells (IICs). All samples PD-L1+ on NCs were also on IICs. Three types of cancers could be grouped: group A(NCs-/ IICs-); group B (NCs-/ IICs+); group C (NCs+/IICs+). To group A belong tumors characterized by poorly immunogenic competence, poor immune response but massive granulocyte infiltrate, justifying the absence of PD-L1 as an immunoinhibitor receptor. To Group B probably belong more immunogenic CRCs, justifying the strong IICs-mediated immune response, and up-regulation of PD-L1 expression only on IICs. To group C belong CRCs probably characterized by a large amount of tumor neoantigens resulting in a marked infiltration of lymphocytes and PD-L1 upregulation also in NCs. Sixty-three colorectal cancer specimens from a cohort of 61 patients were retrospectively reviewed. Thirty-seven MSS and 26 MSI-H CRCs enrolled in this study. Immunohistochemical staining to PD-L1 was performed by using MAb E1L3N. Our study calls attention to the importance to assess PD-L1 expression in tumor microenvironment also evaluating type and density of infiltrating immune cells t...Continue Reading

References

Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G LanzaA Santini
Apr 27, 2001·Trends in Immunology·H Nishimura, T Honjo
Dec 1, 2004·Proceedings of the National Academy of Sciences of the United States of America·R Houston ThompsonEugene D Kwon
Apr 20, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yuichiro OhigashiYoshiyuki Nakajima
Dec 7, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Olivier BuhardRichard Hamelin
Feb 28, 2006·Trends in Immunology·Taku Okazaki, Tasuku Honjo
Apr 12, 2006·The Journal of Experimental Medicine·Mary E KeirArlene H Sharpe
May 2, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Frede Donskov, Hans von der Maase
Dec 1, 2006·Annual Review of Immunology·Gabriel A RabinovichEduardo M Sotomayor
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Junzo HamanishiShingo Fujii
Jan 5, 2008·Annual Review of Immunology·Mary E KeirArlene H Sharpe
Sep 2, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hanne Krogh JensenHans von der Maase
Jul 5, 2011·Cancer Research·Magali TermeLaurence Zitvogel
Mar 23, 2012·Nature Reviews. Cancer·Drew M Pardoll
Mar 13, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Raoul A DroeserLuigi Tornillo
Feb 7, 2014·International Journal of Cancer. Journal International Du Cancer·Inbal MishalianZvi G Fridlender
Apr 10, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Janis M TaubeRobert A Anders
Aug 21, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sabine VenderboschMiriam Koopman
Dec 3, 2014·Trends in Molecular Medicine·Kim C OhaegbulamXingxing Zang
Jun 2, 2015·The New England Journal of Medicine·Dung T LeLuis A Diaz
Jun 27, 2015·PloS One·Pin WuJian Huang
Jul 15, 2015·Oncoimmunology·Franck Housseau, Nicolas J Llosa
Feb 18, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jonathan C DudleyJames R Eshleman
Mar 12, 2016·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Kenneth FriedmanMurray B Resnick
May 5, 2016·Cancer Biology & Medicine·Kanwal Tariq, Kulsoom Ghias
May 21, 2016·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Matthew W RosenbaumMari Mino-Kenudson
May 24, 2016·International Journal of Molecular Sciences·Giosuè ScognamiglioGerardo Botti
Jul 13, 2016·British Journal of Cancer·Jung Ho KimGyeong Hoon Kang
Oct 28, 2016·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Lik Hang LeeJinru Shia
Sep 27, 2016·Annals of Translational Medicine·David Lynch, Adrian Murphy
Oct 18, 2016·Journal of Gastrointestinal Oncology·Manojkumar Bupathi, Christina Wu
Nov 3, 2016·The New England Journal of Medicine·Vassiliki A Boussiotis
Nov 5, 2016·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Shingo InagumaMarkku Miettinen
Feb 28, 2017·Journal for Immunotherapy of Cancer·Miles C Andrews, Jennifer A Wargo
Mar 8, 2017·Journal of Leukocyte Biology·Merav E Shaul, Zvi G Fridlender
Jun 22, 2017·International Journal of Molecular Sciences·Alessandro PassardiPaola Ulivi

❮ Previous
Next ❯

Citations

Mar 12, 2019·The International Journal of Biological Markers·Young San Ko, Jung-Soo Pyo
Jun 20, 2019·The British Journal of Surgery·T O SilloG Middleton
Jul 15, 2020·Molecular Biology Reports·Parastoo ShakerinMaryam Nourizadeh
Dec 14, 2018·Oncoimmunology·Joanna WalkowskaChristina Therkildsen
Oct 20, 2020·MedComm·Antonio B WardGary A Piazza
Sep 13, 2018·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Carolina Martinez-CiarpagliniAndres Cervantes
Dec 5, 2020·International Journal of Molecular Sciences·Marina ChulkinaIrina V Pinchuk
Dec 19, 2019·RNA Biology·Shengyun MaWendy Jia Men Huang
Feb 10, 2020·International Journal of Radiation Oncology, Biology, Physics·Steven N SeyedinJoseph M Caster
Jul 3, 2021·Cancers·Justyna Magdalena HermanowiczDariusz Pawlak
May 24, 2021·Molecular Therapy : the Journal of the American Society of Gene Therapy·Zeting YuanKe Xu
Nov 16, 2021·Cellular and Molecular Gastroenterology and Hepatology·Zhongcheng ShiJames Versalovic

❮ Previous
Next ❯

Methods Mentioned

BETA
surgical resection
PCR

Software Mentioned

STATA
PyroMark Q24

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.